About me

Elías Campo is Professor of Pathology and Senior Consultant at the Hospital Clinic of Barcelona, University of Barcelona. His research focuses on the molecular and genetic characterization of lymphoid neoplasms. In the last years his work has concentrated on elucidating the genomic and functional alterations in chronic lymphocytic leukemia, mantle cell lymphoma, and other aggressive lymphomas, their role in the pathogenesis of these diseases and their impact in the clinical management of patients. He has been co-director of the Spanish CLL genome project in the International Cancer Genome Consortium. He is member of the USA National Academy of Medicine since 2018.

Featured publications

  • The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee

    Authors: Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d'Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD .
    Reference: Blood 2022.
  • Molecular map of chronic lymphocytic leukemia and its impact on outcome

    Authors: Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, Stevenson KE, Tausch E, Delgado J, Barbera-Mourelle A, Taylor-Weiner A, Bousquets-Muñoz P, Diaz-Navarro A, Dunford A, Anand S, Kretzmer H, Gutierrez-Abril J, López-Tamargo S, Fernandes SM, Sun C, Sivina M, Rassenti LZ, Schneider C, Li S, Parida L, Meissner A, Aguet F, Burger JA, Wiestner A, Kipps TJ, Brown JR, Hallek M, Stewart C, Neuberg DS, Martín-Subero JI, Puente XS, Stilgenbauer S, Wu CJ, Campo E, Getz G .
    Reference: Nature Genetics 2022.
  • Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

    Authors: Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, Dawson KJ, Kulis M, Diaz-Navarro A, Villamor N, Melero JL, Chapaprieta V, Dueso-Barroso A, Delgado J, Moia R, Ruiz-Gil S, Marchese D, Giró A, Verdaguer-Dot N, Romo M, Clot G, Rozman M, Frigola G, Rivas-Delgado A, Baumann T, Alcoceba M, González M, Climent F, Abrisqueta P, Castellví J, Bosch F, Aymerich M, Enjuanes A, Ruiz-Gaspà S, López-Guillermo A, Jares P, Beà S, Capella-Gutierrez S, Gelpí JL, López-Bigas N, Torrents D, Campbell PJ, Gut I, Rossi D, Gaidano G, Puente XS, Garcia-Roves PM, Colomer D, Heyn H, Maura F, Martín-Subero JI, Campo E .
    Reference: Nature Medicine 2022.
  • IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

    Authors: Nadeu F, Royo R, Clot G, Duran-Ferrer M, Navarro A, Martín S, Lu J, Zenz T, Baumann T, Jares P, Puente XS, Martín-Subero JI, Delgado J, Campo E .
    Reference: Blood 2021.
  • Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes

    Authors: Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggros M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, López-Guillermo A, Küppers R, Martin-Subero JI, Puente XS, Beà S, Campo E .
    Reference: Blood 2020.
  • IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

    Authors: Nadeu, F; Mas-de-les-Valls, R; Navarro, A; Royo, R; Martin, S; Villamor, N; Suarez-Cisneros, H; Mares, R; Lu, JY; Enjuanes, A; Rivas-Delgado, A; Aymerich, M; Baumann, T; Colomer, D; Delgado, J; Morin, RD; Zenz, T; Puente, XS; Campbell, PJ; Bea, S; Maura, F; Campo, E.
    Reference: Nature Communications 2020.
  • CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma

    Authors: Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, López-Otín C, Salaverria I, Puente XS, Campo E, Beà S .
    Reference: Blood 2019.
  • A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

    Authors: Clot, Guillem; Jares, Pedro; Gine, Eva; Navarro, Alba; Royo, Cristina; Pinyol, Magda; Martin-Garcia, David; Demajo, Santiago; Espinet, Blanca; Salar, Antonio; Ferrer, Ana; Muntanola, Ana; Aymerich, Marta; Rauert-Wunderlich, Hilka; Jaffe, Elaine S.; Connors, Joseph M.; Gascoyne, Randy D.; Delabie, Jan; Lopez-Guillermo, Armando; Ott, German; Wright, George W.; Staudt, Louis M.; Rosenwald, Andreas; Scott, David W.; Rimsza, Lisa M.; Bea, Silvia; Campo, Elias;.
    Reference: Blood 2018.
  • Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

    Authors: Karube, K.; Enjuanes, A.; Dlouhy, I.; Jares, P.; Martin-Garcia, D.; Nadeu, F.; Ordonez, G. R.; Rovira, J.; Clot, G.; Royo, C.; Navarro, A.; Gonzalez-Farre, B.; Vaghefi, A.; Castellano, G.; Rubio-Perez, C.; Tamborero, D.; Briones, J.; Salar, A.; Sancho, J. M.; Mercadal, S.; Gonzalez-Barca, E.; Escoda, L.; Miyoshi, H.; Ohshima, K.; Miyawaki, K.; Kato, K.; Akashi, K.; Mozos, A.; Colomo, L.; Alcoceba, M.; Valera, A.; Carrio, A.; Costa, D.; Lopez-Bigas, N.; Schmitz, R.; Staudt, L. M.; Salaverria, I.; Lopez-Guillermo, A.; Campo, E.;.
    Reference: Leukemia 2018.
  • Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

    Authors: Nadeu, F; Clot, G; Delgado, J; Martin-Garcia, D; Baumann, T; Salaverria, I; Bea, S; Pinyol, M; Jares, P; Navarro, A; Suarez-Cisneros, H; Aymerich, M; Rozman, M; Villamor, N; Colomer, D; Gonzalez, M; Alcoceba, M; Terol, MJ; Navarro, B; Colado, E; Payer, AR; Puente, XS; Lopez-Otin, C; Lopez-Guillermo, A; Enjuanes, A; Campo, E.
    Reference: Leukemia 2018.

Featured Projects

  • Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

    Principal investigator: Elías Campo Güerri
    Funder: National Institute of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)
    Code: 1P01CA229100
    Duration: 01/09/2019 - 31/08/2024
  • Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)

    Principal investigator: Elías Campo Güerri
    Funder: European Commission
    Code: H2020-ERC-Sy_2018 (810287)
    Duration: 01/04/2019 - 31/03/2024
  • CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

    Principal investigator: Elías Campo Güerri
    Funder: La Caixa Foundation
    Code: HR17-00221_ LCF/PR/HR17/52150017
    Duration: 31/12/2018 - 31/12/2022
  • EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine

    Principal investigator: Elías Campo Güerri
    Funder: European Commission
    Code: CE_H2020-SC1_18_1s 825835
    Duration: 01/01/2019 - 30/06/2023
  • La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia.

    Principal investigator: Elías Campo Güerri
    Funder: Generalitat de Catalunya
    Code: SLT002/16/00374
    Duration: 27/03/2017 - 31/12/2023